Utility of the low-accelerating-dose regimen in 182 liver recipients with recurrent hepatitis C virus

AIM: To describe our experience using a low-accelerating-dose regimen (LADR) with pegylated interferon alpha-2a and ribavirin in treatment of hepatitis C virus (HCV) recurrence. METHODS: From 2003, a protocolized LADR strategy was employed to treat liver transplant (LT) recipients with recurrent HCV...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:World J Gastroenterol
Main Authors: Lim, Kieron BL, Sima, Hamid R, Fiel, M Isabel, Khaitova, Viktoriya, Doucette, John T, Chernyiak, Maria, Ahmad, Jawad, Bach, Nancy, Chang, Charissa, Grewal, Priya, Kim-Schluger, Leona, Liu, Lawrence, Odin, Joseph, Perumalswami, Ponni, Florman, Sander S, Schiano, Thomas D
Formato: Artigo
Idioma:Inglês
Publicado em: Baishideng Publishing Group Inc 2015
Assuntos:
Retrospective Study
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4445100/
https://ncbi.nlm.nih.gov/pubmed/26034358
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v21.i20.6236
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados